Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Neoplasm Metastasis 2Sarcoma, Synovial 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rectal Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Myelodysplastic Syndromes 1Melanoma 1Liposarcoma, Myxoid 1Graft vs Host Disease 1Colonic Neoplasms 1Carcinoma, Merkel Cell 1

Interventions

thymoglobulin 2Thiotepa 2Stem Cell Transplantation 2Melphalan 2Ifosfamide 2Etoposide 2Bone Marrow Transplantation 2Antilymphocyte Serum 2sodium thiosulfate 1ribociclib 1omburtamab I-131 1lexatumumab 1ganitumab 1fludarabine phosphate 1copanlisib 1bempegaldesleukin 1X-Rays 1Vincristine 1Topotecan 1Temozolomide 1Tacrolimus 1Specimen Handling 1Rituximab 1Receptor Protein-Tyrosine Kinases 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Polymerase Chain Reaction 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Rhabdomyosarcoma × Interferon-gamma × Clear all
NCT00428272 2019-12-17

HGS-ETR2 to Treat Children With Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
30 enrolled
CNSSarcoma

Neoplasm Metastasis, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡